Literature DB >> 11316850

Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis.

Hans-Joachim Anders1, Volker Vielhauer1, Matthias Kretzler1, Clemens D Cohen1, Stephan Segerer1, Bruno Luckow1, Lars Weller1, Hermann-Josef Gröne2, Detlef Schlöndorff1.   

Abstract

Chemokines participate in leukocyte infiltration, which plays a major role in glomerular injury during immune complex glomerulonephritis (IC-GN). Because target cell expression of chemokine receptors (CCR) is thought to mediate leukocyte migration, the expression pattern of chemokines and CCR in a model of IC-GN was examined. The transient course and predominant glomerular pathology of this model allows the examination of both the induction and resolution phases of IC-GN. GN was induced in mice by daily apoferritin injection for 2 wk. Urine samples and kidneys were obtained at 1, 2, and 4 wk. Albuminuria was noted at 2 wk, but resolved after 4 wk. This was associated with glomerular IC deposits and mesangial proliferation. Glomerular macrophage infiltration was prominent at 1 and 2 wk, which resolved at 4 wk. Expression of monocyte chemoattractant protein-1 (MCP-1) and RANTES mRNA was upregulated at week 1 and decreased to control levels at weeks 2 and 4. The expression was localized to glomeruli by in situ hybridization and immunohistochemistry. The mRNA of CCR1, CCR2, and CCR5 but not CCR3 or CCR4 were upregulated at week 1 and decreased at weeks 2 and 4. Expression of CCR5 was located to the glomerulus by in situ hybridization and quantitative reverse transcription-PCR of isolated glomeruli. In summary, in a model of transient IC-GN, MCP-1 and RANTES and their receptors CCR1, CCR2, and CCR5 are expressed early and are already downregulated at the peak of proteinuria and leukocyte infiltration. Resolution of glomerulonephritis is associated with a return to baseline of chemokine and CCR expression. Therefore, it is concluded that glomerular MCP-1 and RANTES production directs circulating leukocytes that express CCR1, CCR2, and CCR5 into the glomerulus. After initiating GN, MCP-1 and RANTES and their receptors are readily downregulated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316850     DOI: 10.1681/ASN.V125919

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  15 in total

1.  Shift of C3 deposition from localization in the glomerulus into the tubulo-interstitial compartment in the absence of secreted IgM in immune complex glomerulonephritis.

Authors:  C Vaculik; B M Rüger; G Yanagida; D Hollemann; A Soleiman; U M Losert; J Chen; M B Fischer
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

2.  Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.

Authors:  Lena Schiffer; Ramalingam Bethunaickan; Meera Ramanujam; Weiqing Huang; Mario Schiffer; Haiou Tao; Michael P Madaio; Michael M Madaio; Erwin P Bottinger; Anne Davidson
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

3.  A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

Authors:  Hans-Joachim Anders; Volker Vielhauer; Michael Frink; Yvonne Linde; Clemens D Cohen; Simone M Blattner; Matthias Kretzler; Frank Strutz; Matthias Mack; Hermann-Josef Gröne; James Onuffer; Richard Horuk; Peter J Nelson; Detlef Schlöndorff
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

4.  A study on the association of autoantibodies, chemokine, and its receptor with disease activity in systemic lupus erythematosus in North Indian population.

Authors:  Leishangthem Bidyalaxmi Devi; Archana Bhatnagar; Ajay Wanchu; Aman Sharma
Journal:  Rheumatol Int       Date:  2013-07-06       Impact factor: 2.631

5.  RANTES deficiency attenuates autoantibody-induced glomerulonephritis.

Authors:  Chun Xie; Kui Liu; Yuyang Fu; Xiangmei Qin; Geetha Jonnala; Tao Wang; Hong W Wang; Michael Maldonado; Xin J Zhou; Chandra Mohan
Journal:  J Clin Immunol       Date:  2010-10-01       Impact factor: 8.317

Review 6.  Mechanisms of disease: regulation of RANTES (CCL5) in renal disease.

Authors:  Alan M Krensky; Yong-Tae Ahn
Journal:  Nat Clin Pract Nephrol       Date:  2007-03

7.  Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis.

Authors:  Christian S Haas; Valentina Câmpean; Alexander Kuhlmann; Arno Dimmler; Udo Reulbach; Christian Forster; Thomas Aigner; Till Acker; Karl Plate; Kerstin Amann
Journal:  Virchows Arch       Date:  2006-11-22       Impact factor: 4.064

8.  Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcal glomerulonephritis.

Authors:  Nesrin Besbas; Fatih Ozaltin; Ferhat Catal; Seza Ozen; Rezan Topaloglu; Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

9.  Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis.

Authors:  Koji Tsugawa; Eishin Oki; Koichi Suzuki; Tadaatsu Imaizumi; Etsuro Ito; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

10.  Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.

Authors:  Lihua Bao; Ying Wang; Peili Chen; Menaka Sarav; Mark Haas; Andrew W Minto; Miglena Petkova; Richard J Quigg
Journal:  Immunology       Date:  2009-03-26       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.